Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Baretton, Gustavo  (4)
  • Froehner, Michael  (4)
  • Platzek, Ivan  (4)
Type of Medium
Publisher
Language
Years
Subjects(RVK)
  • 1
    In: BJU International, Wiley, Vol. 121, No. 1 ( 2018-01), p. 53-60
    Abstract: To evaluate the value of multiparametric magnetic resonance imaging (mp MRI ) in the detection of significant prostate cancer ( PC a) and to compare transperineal MRI /ultrasonography fusion biopsy (fusPbx) with conventional transrectal systematic biopsy (sysPbx) in biopsy‐naïve patients. Patients and Methods This multicentre, prospective trial investigated biopsy‐naïve patients with suspicion of PC a undergoing transperineal fusPbx in combination with transrectal sysPbx (comPbx). The primary outcome was the detection of significant PC a, defined as Gleason pattern 4 or 5. We analysed the results after a study period of 2 years. Results The study included 214 patients. The median (range) number of targeted and systematic cores was 6 (2–15) and 12 (6–18), respectively. The overall PC a detection rate of comPbx was 52%. FusPbx detected more PC a than sysPbx (47% vs 43%; P = 0.15). The detection rate of significant PC a was 38% for fusPbx and 35% for sysPbx ( P = 0.296). The rate of missed significant PC a was 14% in fusPbx and 21% in sysPbx. ComPbx detected significantly more significant PC a than fusPbx and sysPbx alone (44% vs 38% vs 35%; P 〈 0.005). In patients presenting with Prostate Imaging Reporting and Data System ( PI ‐ RADS ) 4 and 5 lesions there was a higher detection rate of significant PC a than in patients presenting with PI ‐ RADS ≤3 lesions in comPbx (61% vs 14%; P 〈 0.005). Conclusions For biopsy‐naïve men with tumour‐suspicious lesions in mp MRI , the combined approach outperformed both fusPbx and sysPbx in the detection of overall PC a and significant PC a. Thus, biopsy‐naïve patients may benefit from sysPbx in combination with mp MRI targeted fusPbx.
    Type of Medium: Online Resource
    ISSN: 1464-4096 , 1464-410X
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2018
    detail.hit.zdb_id: 2019983-1
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    In: BJU International, Wiley, Vol. 118, No. 2 ( 2016-08), p. 213-220
    Abstract: To compare multiparametric magnetic resonance imaging (mp MRI ) of the prostate and histological findings of both targeted MRI /ultrasonography‐fusion prostate biopsy ( PB x) and systematic PB x with final histology of the radical prostatectomy ( RP ) specimen. Patients and Methods A total of 105 patients with prostate cancer ( PC a) histopathologically proven using a combination of fusion Pbx and systematic PB x, who underwent RP , were investigated. All patients had been examined using mp MRI , applying the European Society of Urogenital Radiology criteria. Histological findings from the RP specimen were compared with those from the PB x. Whole‐mount RP specimen and mp MRI results were directly compared by a uro‐pathologist and a uro‐radiologist in step‐section analysis. Results In the 105 patients with histopathologically proven PC a by combination of fusion PB x and systematic PB x, the detection rate of PC a was 90% (94/105) in fusion PB x alone and 68% (72/105) in systematic PB x alone ( P = 0.001). The combination PB x detected 23 (22%) Gleason score ( GS ) 6, 69 (66%) GS 7 and 13 (12%) GS ≥8 tumours. Fusion PB x alone detected 25 (26%) GS 6, 57 (61%) GS 7 and 12 (13%) GS ≥8 tumours. Systematic PB x alone detected 17 (24%) GS 6, 49 (68%) GS 7 and 6 (8%) GS ≥8 tumours. Fusion PB x alone would have missed 11 tumours (4% [4/105] of GS 6, 6% [6/105] of GS 7 and 1% [1/105] of GS ≥8 tumours). Systematic PB x alone would have missed 33 tumours (10% [10/105] of GS 6, 20% [21/105] of GS 7 and 2% [2/105] of GS ≥8 tumours). The rates of concordance with regard to GS between the PB x and RP specimen were 63% ( n = 65), 54% ( n = 56) and 75% ( n = 78) in fusion, systematic and combination PB x (fusion and systematic PB x combined), respectively. Upgrading of the GS between PB x and RP specimen occurred in 33% ( n = 34), 44% ( n = 46) and 18% ( n = 19) in fusion, systematic and combination PB x, respectively. γ‐correlation for detection of any cancer was 0.76 for combination PB x, 0.68 for fusion PB x alone and 0.23 for systematic PB x alone. In all, 84% ( n = 88) of index tumours were identified by mp MRI ; 86% ( n = 91) of index lesions on the mp MRI were proven in the RP specimen. Conclusions Fusion PB x of tumour‐suspicious lesions on mp MRI was associated with a higher detection rate of more aggressive PC a and a better tumour prediction in final histopathology than systematic PB x alone; however, combination PB x had the best concordance for the prediction of GS . Furthermore, the additional findings of systematic PB x reflect the multifocality of PC a, therefore, the combination of both biopsy methods would still represent the best approach for the prediction of the final tumour grading in PC a.
    Type of Medium: Online Resource
    ISSN: 1464-4096 , 1464-410X
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2016
    detail.hit.zdb_id: 2019983-1
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    In: Urologia Internationalis, S. Karger AG, Vol. 102, No. 1 ( 2019), p. 20-26
    Abstract: 〈 b 〉 〈 i 〉 Objectives: 〈 /i 〉 〈 /b 〉 We compared the transperineal MRI/ultrasound-fusion biopsy (fusPbx) to transrectal systematic biopsy (sysPbx) in patients with previously negative biopsy and investigated the prediction of tumour aggressiveness with regard to radical prostatectomy (RP) specimen. 〈 b 〉 〈 i 〉 Material and Methods: 〈 /i 〉 〈 /b 〉 A total of 710 patients underwent multiparametric magnetic resonance imaging (mpMRI), which was evaluated in accordance with Prostate Imaging Reporting and Data System (PI-RADS). The maximum PI-RADS (maxPI-RADS) was defined as the highest PI-RADS of all lesions detected in mpMRI. In case of proven prostate cancer (PCa) and performed RP, tumour grading of the biopsy specimen was compared to that of the RP. Significant PCa (csPCa) was defined according to Epstein criteria. 〈 b 〉 〈 i 〉 Results: 〈 /i 〉 〈 /b 〉 Overall, scPCa was detected in 40% of patients. The detection rate of scPCa was 33% for fusPbx and 25% for sysPbx alone ( 〈 i 〉 p 〈 /i 〉 & #x3c; 0.005). Patients with a maxPI-RADS ≥3 and a prostate specific antigen (PSA)-density ≥0.2 ng/mL 〈 sup 〉 2 〈 /sup 〉 harboured more csPCa than those with a PSA-density & #x3c; 0.2 ng/mL 〈 sup 〉 2 〈 /sup 〉 (41% [33/81] vs. 20% [48/248] ; 〈 i 〉 p 〈 /i 〉 & #x3c; 0.001). Compared to the RP specimen ( 〈 i 〉 n 〈 /i 〉 = 140), the concordance of tumour grading was 48% (γ = 0.57), 36% (γ = 0.31) and 54% (γ = 0.6) in fusPbx, sysPbx and comPbx, respectively. 〈 b 〉 〈 i 〉 Conclusions: 〈 /i 〉 〈 /b 〉 The combination of fusPbx and sysPbx outperforms both biopsy modalities in patients with re-biopsy. Additionally, the PSA-density may represent a predictor for csPCa in patients with maxPI-RADS ≥3.
    Type of Medium: Online Resource
    ISSN: 0042-1138 , 1423-0399
    RVK:
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2019
    detail.hit.zdb_id: 1464417-4
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    In: BJU International, Wiley, Vol. 116, No. 6 ( 2015-12), p. 873-879
    Abstract: To compare targeted, transperineal magnetic resonance imaging ( MRI )/ultrasound ( US )‐fusion biopsy to systematic transrectal biopsy in patients with previous negative or first prostate biopsy and to evaluate the gain in diagnostic information with systematic biopsies in addition to targeted MRI / US ‐fusion biopsies. Patients and Methods In all, 263 consecutive patients with suspicion of prostate cancer were investigated. All patients were evaluated by 3‐T multiparametric MRI (mp MRI ) applying the European Society of Urogenital Radiology criteria. All patients underwent MRI / US ‐fusion biopsy transperineally (mean nine cores) and additionally a systematic transrectal biopsy (mean 12 cores). Results In all, 195 patients underwent repeat biopsy and 68 patients underwent first biopsy. The median age was 66 years, median PSA level was 8.3 ng/ mL and median prostate volume was 50  mL . Overall, the prostate cancer detection rate was 52% (137/263). MRI / US ‐fusion biopsy detected significantly more cancer than systematic prostate biopsy (44% [116/263] vs 35% [91/263] ; P = 0.002). In repeat biopsy, the detection rate was 44% (85/195) in targeted and 32% (62/195) in systematic biopsy ( P = 0.002). In first biopsy, the detection rate was 46% (31/68) in targeted and 43% (29/68) in systematic biopsy ( P  = 0.527). In all, 80% (110/137) of biopsy confirmed prostate cancers were clinically significant. For the upgrading of Gleason score, 44% (32/72) more clinically significant prostate cancer was detected by using additional targeted biopsy than by systematic biopsy alone. Conversely, 12% (10/94) more clinically significant cancer was found by systematic biopsy additionally to targeted biopsy. Conclusions MRI / US ‐fusion biopsy was associated with a higher detection rate of clinically significant prostate cancer while taking fewer cores, especially in patients with prior negative biopsy. Due to a high portion of additional tumours with Gleason score ≥7 detected in addition to targeted biopsy, systematic biopsy should still be performed additionally to targeted biopsy.
    Type of Medium: Online Resource
    ISSN: 1464-4096 , 1464-410X
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2015
    detail.hit.zdb_id: 2019983-1
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages